CAS: 615-35-0; N,N'-Dimethyloxamide

相似化合物

3551-78-8 471-46-5 1608-14-6

上下游产品

sarcosine anhydride N,N''-dimethyl-oxalamidineN,N''-dimethyl-oxalamidine N-cyan°Carbonyl-N,N'-dimethyl-ureaN-cyan°Carbonyl-N,N'-dimethyl-urea 1,3-dimethyluric acid1,4-dimethylpiperazine-2,3,5,6-tetrone N,N'-dimethyl-N,N'-dinitroso-oxamide N-methyl-5-chloroimidazole N,N'-dimethyldithiooxamide

1,3,7-三甲基尿酸置于lead Dioxide体系中,化学反应生成 N,N'-二甲基草酰胺
参考文献:Biltz,Chemische Berichte,1911,Vol. 44,P. 285,294
标题:Biltz,Chemische Berichte,1911,Vol. 44,P. 285,294

专利信息

专利号:US-6670506-B2
优先权日:2000-03-02
标 题:Method for producing dinitro-diaza-alkanes and interediate products thereof
发明人：KNOTT THOMAS
权利人:NITROCHEMIE ACHAU GMBH
摘要:A method of synthesis of dinitro-diaza-alkanes and intermediate products thereto from alkylamines and esters, whereby a dialkyl ester of a dicarboxylic acid is reacted with an alkylamine in an aqueous medium to form the corresponding dialkyldiamide of the dicarboxylic acid;the resulting dialkyldiamide is nitrated by means of conventional nitration agents to form the corresponding dialkyldinitroamide of the dicarboxylic acid and;the resulting dialkyldinitroamide is reacted with methylamine and/or ethylamine in an aquous medium to yield a corresponding alkylnitroamine and the dimethyldiamide and/or diethyldiamide of the dicarboxylic acid, and the alkylnitroamine is isolated from that, and the isolated alkylnitroamine is condensed in a known manner to form the dinitro-diaza-alkanes.

专利号:EP-2725028-A1
优先权日:2008-10-22
标题 :Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors

专利号:EP-2725028-B1
优先权日:2008-10-22
标题 :Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors

专利号:US-10858359-B2
优先权日:2016-06-07
标题 :Heterocyclic ring derivatives useful as SHP2 inhibitors
发明人：MA CUNBO; GAO PANLIANG; CHU JIE; WU XINPING; WEN CHUNWEI; KANG DI; BAI JINLONG; PEI XIAOYAN
权利人:JACOBIO PHARMACEUTICALS CO LTD
摘要:Provided are certain novel pyrazine derivatives (I) as SHP2 inhibitors which is shown as formula (I), their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided are fused heterocyclic derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.